A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

An international team of researchers, led by the University of Glasgow, hopes to find new ways to target opioid addiction ...

University of Mississippi researchers have discovered how a compound found in cannabis might be used to mitigate the negative ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...

The encouraging result comes just days after the US FDA approved Vertex Pharma's non-opioid painkiller Journavx (suzetrigine) ...

Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...

SOUTH SAN FRANCISCO, Calif. - Vistagen Therapeutics (VTGN), a clinical-stage biopharmaceutical company with a market ...

The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...